nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-TNF treatment failure: drug levels, immunogenicity, or both?
|
Magro, Fernando |
|
2019 |
4 |
5 |
p. 326-327 |
artikel |
2 |
A watershed moment in tackling childhood obesity
|
The Lancet Gastroenterology & Hepatology, |
|
2019 |
4 |
5 |
p. 325 |
artikel |
3 |
Chromoendoscopy for detection of proximal serrated lesions in routine screening colonoscopy
|
Buchner, Anna |
|
2019 |
4 |
5 |
p. 329-331 |
artikel |
4 |
Correction to Lancet Gastroenterol Hepatol 2019; 4: 135–84
|
|
|
2019 |
4 |
5 |
p. e4 |
artikel |
5 |
Disease modifying therapy in short bowel syndrome: finally coming of age?
|
Vanuytsel, Tim |
|
2019 |
4 |
5 |
p. 328-329 |
artikel |
6 |
ECCO Congress 2019
|
Feetham, Laura |
|
2019 |
4 |
5 |
p. 337 |
artikel |
7 |
Eliminating hepatitis C in Europe
|
Lazarus, Jeffrey V |
|
2019 |
4 |
5 |
p. 335-336 |
artikel |
8 |
Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial
|
Hurt, Chris |
|
2019 |
4 |
5 |
p. 364-375 |
artikel |
9 |
Gauze-like appearance of the sigmoid colon
|
Hata, Keisuke |
|
2019 |
4 |
5 |
p. 412 |
artikel |
10 |
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial
|
Naimi, Rahim M |
|
2019 |
4 |
5 |
p. 354-363 |
artikel |
11 |
How best to treat older patients with metastatic colorectal cancer?
|
Taieb, Julien |
|
2019 |
4 |
5 |
p. 331-333 |
artikel |
12 |
Porto-sinusoidal vascular disease: proposal and description of a novel entity
|
De Gottardi, Andrea |
|
2019 |
4 |
5 |
p. 399-411 |
artikel |
13 |
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
|
Kennedy, Nicholas A |
|
2019 |
4 |
5 |
p. 341-353 |
artikel |
14 |
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
|
Li, Jie |
|
2019 |
4 |
5 |
p. 389-398 |
artikel |
15 |
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
|
Winther, Stine Braendegaard |
|
2019 |
4 |
5 |
p. 376-388 |
artikel |
16 |
Research in brief
|
Baker, Holly |
|
2019 |
4 |
5 |
p. 338 |
artikel |
17 |
Spare parts: an exploration of transplantation
|
Burki, Talha Khan |
|
2019 |
4 |
5 |
p. 340 |
artikel |
18 |
The increasing clinical burden of NAFLD in Asia
|
De Roza, Marianne Anastasia |
|
2019 |
4 |
5 |
p. 333-334 |
artikel |
19 |
The low-fibre diet: contender in IBD, or has it had its time?
|
Yao, Chu K |
|
2019 |
4 |
5 |
p. 339 |
artikel |